The vaccine, called Hayat-Vax [Hayat means life in Arabic], is the first indigenous COVID-19 vaccine in the region that will be manufactured by a newly created joint venture between Sinopharm CNBG, one of the largest pharmaceutical companies in the world that have supplied over 100 million doses of the COVID-19 vaccine globally, and G42, the leading technology company based in Abu Dhabi.
Courtesy G42 Healthcare/Julphar